238 related articles for article (PubMed ID: 25246081)
1. Tracking the origin of metastatic prostate cancer.
Lindberg J; Kristiansen A; Wiklund P; Grönberg H; Egevad L
Eur Urol; 2015 May; 67(5):819-22. PubMed ID: 25246081
[TBL] [Abstract][Full Text] [Related]
2. Re: Johan Lindberg, Anna Kristiansen, Peter Wiklund, Henrik Grönberg, Lars Egevad. Tracking the Origin of Metastatic Prostate Cancer. Eur Urol 2015;67:819-22.
Piva F; Santoni M; Scarpelli M; Briganti A; Montorsi F; Montironi R
Eur Urol; 2015 Dec; 68(6):e134-5. PubMed ID: 26215609
[No Abstract] [Full Text] [Related]
3. The genomic diversity of prostate cancer: our Achilles heel explored.
Bryant RJ; Verrill C; Hamdy FC
Eur Urol; 2015 May; 67(5):823-4. PubMed ID: 25433913
[No Abstract] [Full Text] [Related]
4. Clinicopathological analysis of intraductal proliferative lesions of prostate: intraductal carcinoma of prostate, high-grade prostatic intraepithelial neoplasia, and atypical cribriform lesion.
Miyai K; Divatia MK; Shen SS; Miles BJ; Ayala AG; Ro JY
Hum Pathol; 2014 Aug; 45(8):1572-81. PubMed ID: 24842280
[TBL] [Abstract][Full Text] [Related]
5. Exome sequencing of prostate cancer supports the hypothesis of independent tumour origins.
Lindberg J; Klevebring D; Liu W; Neiman M; Xu J; Wiklund P; Wiklund F; Mills IG; Egevad L; Grönberg H
Eur Urol; 2013 Feb; 63(2):347-53. PubMed ID: 22502944
[TBL] [Abstract][Full Text] [Related]
6. Is there any prognostic impact of intraductal carcinoma of prostate in initial diagnosed aggressively metastatic prostate cancer?
Zhao T; Liao B; Yao J; Liu J; Huang R; Shen P; Peng Z; Gui H; Chen X; Zhang P; Zhu Y; Li X; Wei Q; Zhou Q; Zeng H; Chen N
Prostate; 2015 Feb; 75(3):225-32. PubMed ID: 25307858
[TBL] [Abstract][Full Text] [Related]
7. Integrative Genomic Analysis of Coincident Cancer Foci Implicates CTNNB1 and PTEN Alterations in Ductal Prostate Cancer.
Gillard M; Lack J; Pontier A; Gandla D; Hatcher D; Sowalsky AG; Rodriguez-Nieves J; Vander Griend D; Paner G; VanderWeele D
Eur Urol Focus; 2019 May; 5(3):433-442. PubMed ID: 29229583
[TBL] [Abstract][Full Text] [Related]
8. ETS gene aberrations in atypical cribriform lesions of the prostate: Implications for the distinction between intraductal carcinoma of the prostate and cribriform high-grade prostatic intraepithelial neoplasia.
Han B; Suleman K; Wang L; Siddiqui J; Sercia L; Magi-Galluzzi C; Palanisamy N; Chinnaiyan AM; Zhou M; Shah RB
Am J Surg Pathol; 2010 Apr; 34(4):478-85. PubMed ID: 20220513
[TBL] [Abstract][Full Text] [Related]
9. Intraductal carcinoma of the prostate without invasive carcinoma on needle biopsy: emphasis on radical prostatectomy findings.
Robinson BD; Epstein JI
J Urol; 2010 Oct; 184(4):1328-33. PubMed ID: 20723921
[TBL] [Abstract][Full Text] [Related]
10. Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression.
Qian J; Hirasawa K; Bostwick DG; Bergstralh EJ; Slezak JM; Anderl KL; Borell TJ; Lieber MM; Jenkins RB
Mod Pathol; 2002 Jan; 15(1):35-44. PubMed ID: 11796839
[TBL] [Abstract][Full Text] [Related]
11. Small cell-like change in prostatic intraepithelial neoplasia, intraductal carcinoma, and invasive prostatic carcinoma: a study of 7 cases.
Lee S; Han JS; Chang A; Ross HM; Montironi R; Yorukoglu K; Lane Z; Epstein JI
Hum Pathol; 2013 Mar; 44(3):427-31. PubMed ID: 23026197
[TBL] [Abstract][Full Text] [Related]
12. Genomic Heterogeneity Within Individual Prostate Cancer Foci Impacts Predictive Biomarkers of Targeted Therapy.
VanderWeele DJ; Finney R; Katayama K; Gillard M; Paner G; Imoto S; Yamaguchi R; Wheeler D; Lack J; Cam M; Pontier A; Nguyen YTM; Maejima K; Sasaki-Oku A; Nakano K; Tanaka H; Vander Griend D; Kubo M; Ratain MJ; Miyano S; Nakagawa H
Eur Urol Focus; 2019 May; 5(3):416-424. PubMed ID: 29398457
[TBL] [Abstract][Full Text] [Related]
13. Improved differentiation between ductal and acinar prostate cancer using three-dimensional histology and biomarkers.
Tarján M; Chen HH; Tot T; Wu W; Lenngren A; Dean PB; Tabár L
Scand J Urol Nephrol; 2012 Aug; 46(4):258-66. PubMed ID: 22519924
[TBL] [Abstract][Full Text] [Related]
14. Intraductal carcinoma of the prostate: a distinct histopathological entity with important prognostic implications.
Henry PC; Evans AJ
J Clin Pathol; 2009 Jul; 62(7):579-83. PubMed ID: 19246509
[TBL] [Abstract][Full Text] [Related]
15. Intraductal carcinoma of the prostate: precursor or aggressive phenotype of prostate cancer?
Bonkhoff H; Wheeler TM; van der Kwast TH; Magi-Galluzzi C; Montironi R; Cohen RJ
Prostate; 2013 Mar; 73(4):442-8. PubMed ID: 22949099
[TBL] [Abstract][Full Text] [Related]
16. Intraductal carcinoma of the prostate in the ejaculatory duct.
Sanchez-Salazar AJ; Basler JW; Nicolas MM
Int J Surg Pathol; 2010 Aug; 18(4):298-9. PubMed ID: 20444733
[TBL] [Abstract][Full Text] [Related]
17. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
Tavora F; Epstein JI
Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological features of prostate cancers detected after an initial diagnosis of 'atypical glands suspicious for cancer'.
Zhou M; Magi-Galluzzi C
Pathology; 2010 Jun; 42(4):334-8. PubMed ID: 20438405
[TBL] [Abstract][Full Text] [Related]
19. p53 alteration in regional lymph node metastases from prostate carcinoma: a marker for progression?
Cheng L; Leibovich BC; Bergstralh EJ; Scherer BG; Pacelli A; Ramnani DM; Zincke H; Bostwick DG
Cancer; 1999 Jun; 85(11):2455-9. PubMed ID: 10357418
[TBL] [Abstract][Full Text] [Related]
20. Metastatic prostate adenocarcinoma to the penis: a series of 29 cases with predilection for ductal adenocarcinoma.
Ellis CL; Epstein JI
Am J Surg Pathol; 2015 Jan; 39(1):67-74. PubMed ID: 25025445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]